Loading...
Loading...
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain hydroxythiohomosildenafil, an analogue of sildenafil which is an ingredient in an FDA-approved drug for the treatment of male erectile dysfunction, making this an unapproved new drug.
cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.